AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tenlivas M 1000mg/20mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Kasnav Pharma

Salt Composition

Metformin (1000mg) + Teneligliptin (20mg)

Overview Tenlivas M 1000mg/20mg Tablet ER

Tenlivas M 1000mg/20mg Extended-Release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and vision loss, potentially lowering the risk of cardiovascular events. Tenlivas M may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal distress. Consistent, daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Continued adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts glycemic control. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, and cephalalgia. Hypoglycemia is a potential side effect, especially when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to initiating therapy, patients with renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to ensure patient safety. Alcohol intake should be minimized due to its hypoglycemic effect. Renal function and blood glucose levels will be monitored by your doctor before and throughout treatment.

Uses of Tenlivas M 1000mg/20mg Tablet ER

Managing Type 2 Diabetes

Major Benefits of Tenlivas M 1000mg/20mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tenlivas M 1000mg/20mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Tenlivas M 1000mg/20mg Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tenlivas M 1000mg/20mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tenlivas M 1000mg/20mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Tenlivas M 1000mg/20mg Tablet ER works:

Tenlivas M extended-release tablets (1000mg/20mg) contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Tenlivas M 1000mg/20mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Tenlivas M 1000mg/20mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Tenlivas M 1000mg/20mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tenlivas M 1000mg/20mg Tablet ER on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Tenlivas M 1000mg/20mg Extended-Release tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised. Tenlivas M 1000mg/20mg Extended-Release tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Tenlivas M 1000mg/20mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Tenlivas M 1000mg/20mg Tablet ER :

Should you forget a Tenlivas M 1000mg/20mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tenlivas M 1000mg/20mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Tenlivas M 1000mg/20mg Tablet ER

Tenlivas M 1000mg/20mg Tablet ER is safe when used as prescribed. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Tenlivas M 1000mg/20mg Tablet ER rarely causes hypoglycemia alone, but it can occur if calorie intake is inadequate. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate low blood sugar. These are more likely if you skip meals, drink alcohol, overexert yourself, or use other diabetes medications. Regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice on hand.
Nausea and vomiting are possible side effects of Tenlivas M 1000mg/20mg Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without your doctor's approval.
Tenlivas M 1000mg/20mg Tablet ER is contraindicated in patients allergic to its components or excipients. It should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tenlivas M 1000mg/20mg Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect involving elevated blood lactic acid. It's avoided in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Tenlivas M 1000mg/20mg Tablet ER and seek immediate medical attention.
Prolonged use of Tenlivas M 1000mg/20mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency can result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. Should you experience these symptoms, consult your physician for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Tenlivas M 1000mg/20mg Ta...
130
MRP 150
13% off